BRENTUXIMAB
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Objectives
CD30 is a protein thought to promote cell proliferation/survival and downregulate the immune response. Twenty percent…
Peripheral T-cell lymphomas (PTCL) are typically associated with poor prognosis. Anthracycline-containing regimens, such as CHOP…
Classical Hodgkin lymphoma (cHL) is characterized genetically by near-universal alterations in 9p24.1, which result in…
The role of autologous hematopoietic stem cell transplantation (ASCT) in the management of non-Hodgkin's lymphoma (NHL) is…
![Graphic][1]
In hematological disorders ALK expression is present in >50% of Anaplastic Large Cell Lymphomas (ALCL) as a…
With the recent approvals of brentuximab for the treatment of refractory Hodgkin lymphoma and ado-trastuzumab emtansine for…